Closed & Collaborative H2 2025: Mergers, acquisitions, partnerships, collaborations, and strategic agreements The second half of 2025 showed pharma and healthcare leaning into partnerships that de‑risk innovation and compress time to market.

#RNA #ADCs #earlyphaseclinicalservices #biosimilars #marketentry #platformlicensing #Radiopharmaceuticals #hospitalAI #CDxpartnerships #genomicsequencing #biomarkerdiscovery #Digitalhealth #biologics #specialtymedicines #precisionmedicine #MandA #licensingagreements
zurl.co/ch3Xg